Norges Bank Olema Pharmaceuticals, Inc. Transaction History

Norges Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2023	BUY	$3.89 - $9.43 $1.57 Million - $3.8 Million	402,900 New	402,900 $1.72 Million
Q1 2022 May 09, 2022	SELL	$3.89 - $9.43 $1.57 Million - $3.8 Million	-402,900 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$8.75 - $30.71 $3.53 Million - $12.4 Million	402,900 New	402,900 $3.77 Million

136

58.8M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $217M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.